Regorafenib for Advanced Gastrointestinal Stromal Tumors Following Imatinib and Sunitinib Treatment: A Subgroup Analysis Evaluating Japanese Patients in the Phase III GRID Trial
International Journal of Clinical Oncology - Japan
doi 10.1007/s10147-015-0790-y
Full Text
Open PDFAbstract
Available in full text
Date
February 6, 2015
Authors
Publisher
Springer Science and Business Media LLC